Proton Pump Inhibitors
Phase 3Small molecule
Proton Pump Inhibitors is one of 6 small molecule programs targeting Pancreatic. It is currently in Phase 3.
2
Indications
5
Total Trials
3
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
5 competitors in Pancreatic
#DrugCompanyPhaseTrials
1Proton Pump Inhibitors
SSamsung Medical Center
Phase 3
Adstiladrin
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 1
Pancreatic Parenchymal of N-Butyl-2-Cyanoacrylate
MMinia University
Phase 2
Synthetic Human Secretin
MMayo Clinic
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Acute Variceal Bleeding1 trial
Esophageal Varices1 trial
Randomized Controlled Trial1 trial
Pancreatic1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Proton Pump Inhibitors. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- SSamsung Medical Center